Item Type | Name |
Concept
|
Migraine Disorders
|
Concept
|
Migraine with Aura
|
Concept
|
Migraine without Aura
|
Academic Article
|
Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.
|
Academic Article
|
Meeting acute migraine treatment needs through novel treatment formulations.
|
Academic Article
|
Association between restless legs syndrome and migraine.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
|
Academic Article
|
Migraine.
|
Academic Article
|
Migraine preventive treatment.
|
Academic Article
|
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.
|
Academic Article
|
Predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate.
|
Academic Article
|
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
|
Academic Article
|
Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
|
Academic Article
|
Randomized, controlled trial of telcagepant over four migraine attacks.
|
Academic Article
|
Migraine in women with chronic pelvic pain with and without endometriosis.
|
Academic Article
|
Frovatriptan as preemptive treatment for fasting-induced migraine.
|
Academic Article
|
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: a response.
|
Academic Article
|
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.
|
Academic Article
|
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
|
Academic Article
|
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
|
Academic Article
|
Chronic migraine--classification, characteristics and treatment.
|
Academic Article
|
Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
|
Academic Article
|
MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine.
|
Academic Article
|
Measuring migraine-related quality of care across 10 health plans.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
Migraine headache is present in the aura phase: a prospective study.
|
Academic Article
|
Psychiatric comorbidities of episodic and chronic migraine.
|
Academic Article
|
Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.
|
Academic Article
|
Migraine triggers: Harnessing the messages of clinical practice.
|
Academic Article
|
Use of common migraine treatments in breast-feeding women: a summary of recommendations.
|
Academic Article
|
Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.
|
Academic Article
|
Gastrointestinal manifestations of migraine: meeting the treatment challenges.
|
Academic Article
|
Sumatriptan : treatment across the full spectrum of migraine.
|
Academic Article
|
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
|
Academic Article
|
Migraine genetics - a review: part I.
|
Academic Article
|
Migraine Genetics: Part II.
|
Academic Article
|
Migraine and autonomic nervous system function: a population-based, case-control study.
|
Academic Article
|
Is there a preferred triptan?
|
Academic Article
|
Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introduction.
|
Academic Article
|
Olanzapine in the treatment of refractory migraine and chronic daily headache.
|
Academic Article
|
Hemicrania continua responds to cyclooxygenase-2 inhibitors.
|
Academic Article
|
Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
|
Academic Article
|
Reliability and validity of the migraine therapy assessment questionnaire.
|
Academic Article
|
Migraine preventive medication reduces resource utilization.
|
Academic Article
|
Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
|
Academic Article
|
The evolving management of migraine.
|
Academic Article
|
Botulinum toxin type A: myths, facts, and current research.
|
Academic Article
|
Neurotoxins in the neurobiology of pain.
|
Academic Article
|
Procedures for administering botulinum toxin type A for migraine and tension-type headache.
|
Academic Article
|
The prevalence of migraine in neurologists.
|
Academic Article
|
Analyses of cost-effectiveness of migraine therapies should consider multiple measures.
|
Academic Article
|
Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model.
|
Academic Article
|
Botulinum toxin and other new approaches to migraine therapy.
|
Academic Article
|
Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
|
Academic Article
|
Migraine.
|
Academic Article
|
Topiramate in migraine prevention: results of a large controlled trial.
|
Academic Article
|
Anticonvulsants in migraine.
|
Academic Article
|
Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.
|
Academic Article
|
Cardiovascular tolerability and safety of triptans: a review of clinical data.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
Study of mitochondrial DNA mutations in patients with migraine with prolonged aura.
|
Academic Article
|
Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.
|
Academic Article
|
A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
|
Academic Article
|
Topiramate monotherapy in epilepsy and migraine prevention.
|
Academic Article
|
Topiramate in migraine prevention.
|
Academic Article
|
Neuroleptics in headache.
|
Academic Article
|
Preventive treatment of headaches.
|
Academic Article
|
Cardiovascular risk factors associated with migraine.
|
Academic Article
|
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
|
Academic Article
|
Burden of illness and satisfaction with care among patients with headache seen in a primary care setting.
|
Academic Article
|
Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size.
|
Academic Article
|
Can allodynic migraine patients be identified interictally using a questionnaire?
|
Academic Article
|
Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
|
Academic Article
|
Headaches in pregnancy.
|
Academic Article
|
Chronic migraine: diagnosis and management strategy.
|
Academic Article
|
Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
|
Academic Article
|
Acute migraine treatment: patterns of use and satisfaction in a clinical population.
|
Academic Article
|
Preventive treatment of migraine.
|
Academic Article
|
The impact of migraine on daily activities: effect of topiramate compared with placebo.
|
Academic Article
|
Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
|
Academic Article
|
How effective is intensive migraine education provided by migraineurs?
|
Academic Article
|
DHE in the pharmacotherapy of migraine: potential for a larger role.
|
Academic Article
|
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.
|
Academic Article
|
Central sensitization theory of migraine: clinical implications.
|
Academic Article
|
Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
|
Academic Article
|
Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials.
|
Academic Article
|
Hemicrania continua-like headache associated with internal carotid artery dissection may respond to indomethacin.
|
Academic Article
|
Diagnostic testing in episodic migraine: should it include magnetic resonance venography?
|
Academic Article
|
Cephalalgiaphobia: a possible specific phobia of illness.
|
Academic Article
|
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.
|
Academic Article
|
Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs.
|
Academic Article
|
Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
|
Academic Article
|
Patients' preference for migraine preventive therapy.
|
Academic Article
|
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy.
|
Academic Article
|
Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes.
|
Academic Article
|
Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
|
Academic Article
|
Quality of care measures for migraine: a comprehensive review.
|
Academic Article
|
Menstrual migraine: a review of hormonal causes, prophylaxis and treatment.
|
Academic Article
|
Combination therapy in acute migraine treatment: the rationale behind the current treatment options.
|
Academic Article
|
Menstrually related migraine: breaking the cycle in your clinical practice.
|
Academic Article
|
The impact of topiramate on health-related quality of life indicators in chronic migraine.
|
Academic Article
|
Cutaneous allodynia in the migraine population.
|
Academic Article
|
Botulinum toxin type A for the treatment of headache: why we say yes.
|
Academic Article
|
Triptans: actions and reactions.
|
Academic Article
|
Episodic migraine associated with postural orthostatic tachycardia syndrome and vasovagal syncope: migraine triggers neuromediated syncope.
|
Academic Article
|
Migraine in pregnancy.
|
Academic Article
|
Treatment recommendations for migraine.
|
Academic Article
|
Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.
|
Academic Article
|
Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.
|
Academic Article
|
Recent developments in migraine.
|
Academic Article
|
Assessing quality of care for migraineurs: a model health plan measurement set.
|
Academic Article
|
Diagnosis and treatment of the menstrual migraine patient.
|
Academic Article
|
Menstrual migraine: case studies of women with estrogen-related headaches.
|
Academic Article
|
Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.
|
Academic Article
|
Preventive migraine treatment.
|
Academic Article
|
Clinical results of botulinum toxin type a treatment of migraine headache.
|
Academic Article
|
Migraine prophylaxis with botulinum toxin A is associated with perception of headache.
|
Academic Article
|
The evolution of chronic migraine: classification and nomenclature.
|
Academic Article
|
Headache prophylaxis with BoNTA: patient characteristics.
|
Academic Article
|
Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
|
Academic Article
|
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
|
Academic Article
|
Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
|
Academic Article
|
Topiramate in migraine prevention.
|
Academic Article
|
Expanding access to triptans: assessment of clinical outcome.
|
Academic Article
|
Is CGRP a marker for chronic migraine?
|
Academic Article
|
Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: A randomized study.
|
Academic Article
|
Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
|
Academic Article
|
Is the migraine brain super-active?
|
Academic Article
|
Operational diagnostic criteria for chronic migraine: expert opinion.
|
Academic Article
|
COX inhibitors for the treatment of migraine.
|
Academic Article
|
Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment.
|
Academic Article
|
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
|
Academic Article
|
Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
|
Academic Article
|
Does migraine produce facial palsy? For whom the Bell tolls.
|
Academic Article
|
Acute migraine treatment.
|
Academic Article
|
The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.
|
Academic Article
|
Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention.
|
Academic Article
|
Efficacy and Tolerability of STOPAIN for a Migraine Attack.
|
Academic Article
|
Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study.
|
Academic Article
|
TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine. Some like it hot! Chronic migraine increases TRPV1 receptors in the scalp.
|
Academic Article
|
AVP-825 Breath-Powered Intranasal Delivery System Containing 22?mg Sumatriptan Powder vs 100?mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks.
|
Academic Article
|
Targeting CGRP: A New Era for Migraine Treatment.
|
Academic Article
|
Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT.
|
Academic Article
|
Late-life migraine accompaniments: A narrative review.
|
Academic Article
|
Preventive Migraine Treatment.
|
Academic Article
|
Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management.
|
Academic Article
|
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
|
Academic Article
|
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
|
Academic Article
|
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
|
Academic Article
|
Considerations for management of migraine symptoms in the primary care setting.
|
Academic Article
|
The Management of Adults With Acute Migraine in the Emergency Department.
|
Academic Article
|
Long-Term Pain Reduction Does Not Imply Improved Functional Outcome in Patients Treated With Combined Supraorbital and Occipital Nerve Stimulation for Chronic Migraine.
|
Academic Article
|
How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine.
|
Academic Article
|
The migraine postdrome: An electronic diary study.
|
Academic Article
|
Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study.
|
Academic Article
|
Inhaled drug therapy development for the treatment of migraine.
|
Academic Article
|
MIGRAINE AND PREGNANCY.
|
Academic Article
|
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
|
Academic Article
|
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
|
Academic Article
|
Erratum to: Targeting CGRP: A New Era for Migraine Treatment.
|
Academic Article
|
Topiramate in Migraine Prevention: A 2016 Perspective.
|
Academic Article
|
AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine.
|
Academic Article
|
Fremanezumab for the Preventive Treatment of Chronic Migraine.
|
Academic Article
|
Migraine and women.
|
Academic Article
|
A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
|
Academic Article
|
Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
|
Academic Article
|
A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study).
|
Academic Article
|
Histamine and Migraine.
|
Academic Article
|
Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study.
|
Academic Article
|
OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.
|
Academic Article
|
Preventive Therapies for Chronic Migraine.
|
Academic Article
|
CGRP Monoclonal Antibodies for Migraine: Rationale and Progress.
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
|
Academic Article
|
Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.
|
Academic Article
|
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
|
Academic Article
|
Erenumab in the treatment of migraine.
|
Academic Article
|
Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review.
|
Academic Article
|
From LBR-101 to Fremanezumab for Migraine.
|
Academic Article
|
CGRP antagonists in the treatment of episodic migraine.
|
Academic Article
|
Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
|
Academic Article
|
The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
|
Academic Article
|
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study.
|
Academic Article
|
Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments.
|
Academic Article
|
Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.
|
Academic Article
|
Current Status of Antiepileptic Drugs as Preventive Migraine Therapy.
|
Academic Article
|
Invited Commentary on Preventive Anti-Migraine Therapy (PAMT).
|
Academic Article
|
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
|
Academic Article
|
The endocannabinoid system in migraine: from bench to pharmacy and back.
|
Academic Article
|
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.
|
Academic Article
|
Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
|
Academic Article
|
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.
|
Academic Article
|
Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.
|
Academic Article
|
Basic Considerations for the Use of Monoclonal Antibodies in Migraine.
|
Academic Article
|
Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
|
Academic Article
|
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
|
Academic Article
|
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.
|
Academic Article
|
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
|
Academic Article
|
Fremanezumab for the preventive treatment of migraine.
|
Academic Article
|
Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.
|
Academic Article
|
Novel Medications for the Treatment of Migraine.
|
Academic Article
|
FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
|
Academic Article
|
Preventive Treatment for Episodic Migraine.
|
Academic Article
|
Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline.
|
Academic Article
|
Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).
|
Academic Article
|
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
|
Academic Article
|
The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings.
|
Academic Article
|
Care Among Migraine Patients in a Commercially Insured Population.
|
Academic Article
|
Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition.
|
Academic Article
|
A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine.
|
Academic Article
|
Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
|
Academic Article
|
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
|
Academic Article
|
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.
|
Academic Article
|
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study.
|
Academic Article
|
Managing migraine in pregnancy and breastfeeding.
|
Academic Article
|
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial.
|
Academic Article
|
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.
|
Academic Article
|
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24?weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
|
Academic Article
|
The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine.
|
Academic Article
|
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
|
Academic Article
|
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.
|
Academic Article
|
Response to "Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice".
|
Academic Article
|
Evaluation of the 6-item Identify Chronic Migraine screener in a large medical group.
|
Academic Article
|
Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data.
|
Academic Article
|
Pooled Analysis of PFO Occluder Device Trials in Patients With PFO and Migraine.
|
Academic Article
|
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine.
|
Academic Article
|
A new hypothesis linking oxytocin to menstrual migraine.
|
Academic Article
|
Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial.
|
Academic Article
|
Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
|
Academic Article
|
Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study.
|
Academic Article
|
Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis.
|
Academic Article
|
Efficacy and quality-of-life improvements with fremanezumab treatment in patients with difficult-to-treat migraine with associated neurological dysfunction.
|
Academic Article
|
Petasites for Migraine Prevention: New Data on Mode of Action, Pharmacology and Safety. A Narrative Review.
|
Academic Article
|
Lidocaine infusions for refractory chronic migraine: a retrospective analysis.
|
Academic Article
|
The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine.
|
Academic Article
|
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
|
Academic Article
|
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale.
|
Academic Article
|
Current and emerging pharmacotherapy for menstrual migraine: a narrative review.
|
Academic Article
|
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
|
Academic Article
|
Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact.
|
Academic Article
|
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study.
|
Academic Article
|
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review.
|
Academic Article
|
Refractory migraine: a cerebrovascular disease?
|
Academic Article
|
Evidence-based preventive treatment of migraine.
|
Academic Article
|
How early can we treat migraine attacks? A perspective based on prodrome.
|
Academic Article
|
Clinical factors associated with day-to-day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data.
|
Academic Article
|
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials.
|
Academic Article
|
Insights from 25?years of onabotulinumtoxinA in migraine - mechanisms and management.
|